PPT-Post-autologous Transplant Therapy for Hodgkin Lymphoma
Author : sherrill-nordquist | Published Date : 2020-04-02
Program Goals cHL Overview cHL Poor Prognosis Risk Factors Case Study 1 45YearOld Man With EarlyStage cHL PostHDTASCT BV Maintenance Phase 3 AETHERA Trial Design
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document " Post-autologous Transplant Therapy for ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Post-autologous Transplant Therapy for Hodgkin Lymphoma: Transcript
Program Goals cHL Overview cHL Poor Prognosis Risk Factors Case Study 1 45YearOld Man With EarlyStage cHL PostHDTASCT BV Maintenance Phase 3 AETHERA Trial Design Phase 3 AETHERA Trial Efficacy Data. Rob Corbett. NCCN. Christchurch. Hodgkin Lymphoma. Great success story!. LMIC. >50% 0-10yrs old. Striking male predominance. Symptoms. 60% < 6months. B symptoms 40%. Wt. loss. Fever. Night sweats. Lauren . Boutwell. MS, RD, LDN. Ming Cheung MS, RD, LDN. Agenda . Lymphoma Overview - L. Nutritional Changes due to Lymphoma - M. Treatment Options - L. Case Study - M. Nutrition Therapy General - L. and their . precursor . cells. . The name often refers to just the . cancerous. . ones . rather than all such . tumors. .. Many lymphomas are known to be due to specific genetic mutations.. 3. rd. Present. . and. . Future. Mustafa CETIN. ,. . MD . December. ,. . 2016. Erciyes University BMT Center. KHUH . , Doctor . Education Program. Passweg . et al. . BMT Feb. . 2016. ASCT in . Europe (2014. Jonathon B. Cohen, MD. Dept of . Hematology. /Medical Oncology. Co-Director . Lymphoma Program. Relapsed aggressive . nhl. associated with shortened survival. Scholar-1 (Crump et al, Blood 2017). Martin et al, Blood 2016. lecture 3. Lecturer . Dr.Mohanad Al-Hindawi. MBCHB, MSc. Histopathology, . CABHS.Anatomical. pathology. Non-Hodgkin lymphoma-Clinical . features . Two thirds of NHLs and . (virtually all Hodgkin lymphomas) . Basics. Lymphoma – a cancer started in the cells of the immune system. 5 types:. Hodgkin Disease. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma in Children. Lymphoma of the Skin. Waldenstrom. . Macroglobulinemia. Non-Hodgkin’s lymphoma (. NHL) is a term covering all . lymphoproliferative. system malignancies except Hodgkin's lymphoma . The disease is rare in subject under 30 years of age and incidence increase with age . Around two-thirds of all cases are diagnosed in people over 60 years . . . Assistant Professor :. Dr.Maysem. . Mouayad. . Alwash. . . . Lymphocytes are the immunologically competent cells that assist the phagocytes in . defence. of the body against infection and other foreign invasion.. How to cite: Kusminsky G, Abriata G, Forman D, Sierra MS (2016).Etiology of Hodgkin lymphoma (C81) in Central and South America.In: Cancer in Central and South America.Lyon: International Agency for What is Hodgkin lymphoma? CANCER CARE Lymph nodes Lymphoma refers to a group of cancers that come from a specic group of white blood cells inside your body. ese cells are called lymphocyt About Indolent Lymphoma Non-Hodgkins lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the bodys immune system. 1 Types of NHL can be g L, FILIPPAP, MOWAN. Primary nasal paranasaloropharyngeal lymphoma in the pediatric agegroup. Cancer 1990; 65: 1438-1444.YP, SYW,XF, ZXH, LRadiotherapy As Primary Treatment for stage IEand IIE nasal na NCCN. Christchurch. Hodgkin Lymphoma. Great success story!. LMIC. >50% 0-10yrs old. Striking male predominance. Symptoms. 60% < 6months. B symptoms 40%. Wt. loss. Fever. Night sweats. Staging.
Download Document
Here is the link to download the presentation.
" Post-autologous Transplant Therapy for Hodgkin Lymphoma"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents